Vitamin D intake may be a predictor of response to aromatase inhibitors in postmenopausal women with hormone receptor positive breast cancer.

Authors	Omer Dizdar, Nilufer Bulut, Kadri Altundag
Journal	Breast cancer research and treatment (Breast Cancer Res Treat) Vol. 109 Issue 2 Pg. 403 (May 2008) ISSN: 0167-6806 [Print] Netherlands
PMID	17624607 (Publication Type: Letter)
Chemical References	Aromatase Inhibitors Vitamin D
Topics	Aromatase Inhibitors (therapeutic use) Breast Neoplasms (drug therapy) Drug Resistance, Neoplasm (physiology) Female Humans Neoplasms, Hormone-Dependent (drug therapy) Postmenopause Vitamin D (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!